首页 > 最新文献

Future Science OA最新文献

英文 中文
Childhood trauma and adolescent substance use: an integrative perspective. 儿童创伤和青少年药物使用:一个综合的观点。
IF 2.1 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2025-09-11 DOI: 10.1080/20565623.2025.2557763
John P Hoffmann, Curtis S Hoffmann

This article addresses the complex relationship between childhood trauma and adolescent substance use. Drawing on evidence from neurodevelopmental, psychological/emotional, behavioral, and social research, we determined that childhood trauma, which includes early life stress, adverse childhood experiences (ACEs), and toxic stress, can upset brain development, emotion regulation, and stress-response systems, thereby creating lasting vulnerabilities. These neurological changes both generate and interact with behavioral traits such as impulsivity, poor coping, and emotional dysregulation, thus increasing the risk of substance use as a dysfunctional coping strategy. Social and environmental factors, such as caregiver substance use, peer influences, and community-level disadvantage, further compound these effects. However, individual traits, including effortful control and supportive relationships can attenuate these risks. Moreover, evidence-based interventions that address integrated, trauma-informed, and developmentally appropriate approaches have demonstrated promise in reducing the risks of adolescent substance use among trauma-exposed youth. The article concludes by calling for more conceptual integration across disciplines, longitudinal studies, and culturally responsive prevention, intervention, and treatment approaches.

这篇文章讨论了童年创伤和青少年药物使用之间的复杂关系。根据神经发育、心理/情感、行为和社会研究的证据,我们确定童年创伤,包括早期生活压力、不良童年经历(ace)和有毒压力,会扰乱大脑发育、情绪调节和压力反应系统,从而造成持久的脆弱性。这些神经学上的改变既会产生冲动、应对能力差、情绪失调等行为特征,也会与之相互作用,从而增加了作为一种功能失调的应对策略而使用药物的风险。社会和环境因素,如照顾者药物使用、同伴影响和社区层面的不利条件,进一步加剧了这些影响。然而,个人特质,包括努力控制和支持关系可以减轻这些风险。此外,以证据为基础的干预措施解决了综合的、创伤知情的和发展适当的方法,在减少暴露于创伤的青少年中青少年物质使用的风险方面表现出了希望。文章最后呼吁更多的跨学科概念整合、纵向研究和文化响应性预防、干预和治疗方法。
{"title":"Childhood trauma and adolescent substance use: an integrative perspective.","authors":"John P Hoffmann, Curtis S Hoffmann","doi":"10.1080/20565623.2025.2557763","DOIUrl":"10.1080/20565623.2025.2557763","url":null,"abstract":"<p><p>This article addresses the complex relationship between childhood trauma and adolescent substance use. Drawing on evidence from neurodevelopmental, psychological/emotional, behavioral, and social research, we determined that childhood trauma, which includes early life stress, adverse childhood experiences (ACEs), and toxic stress, can upset brain development, emotion regulation, and stress-response systems, thereby creating lasting vulnerabilities. These neurological changes both generate and interact with behavioral traits such as impulsivity, poor coping, and emotional dysregulation, thus increasing the risk of substance use as a dysfunctional coping strategy. Social and environmental factors, such as caregiver substance use, peer influences, and community-level disadvantage, further compound these effects. However, individual traits, including effortful control and supportive relationships can attenuate these risks. Moreover, evidence-based interventions that address integrated, trauma-informed, and developmentally appropriate approaches have demonstrated promise in reducing the risks of adolescent substance use among trauma-exposed youth. The article concludes by calling for more conceptual integration across disciplines, longitudinal studies, and culturally responsive prevention, intervention, and treatment approaches.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2557763"},"PeriodicalIF":2.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12427455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145033056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advantages of Hao's esophagogastrostomy by fissure technique: study protocol for a prospective clinical trial. 郝氏食管胃吻合术的优势:前瞻性临床试验的研究方案。
IF 2.1 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2025-07-28 DOI: 10.1080/20565623.2025.2540746
Wen-Liang Cui, Ze-Qin Wang, Ming-Ye Ma, Ya-Ping Wang, Lu-Chun Hua, Jun Hong, Han-Kun Hao

Introduction: In the past, total gastrectomy (TG) was the most common surgical method, but now proximal gastrectomy (PG) has gradually become an alternative surgical method for proximal gastric and esophagogastric junction cancer. However, there is no recognized preferred anastomosis method after PG. In view of this, Hao's esophagogastrostomy by fissure technique (HEFT) proposed by the author's team can reduce the difficulty of the operation and the occurrence of postoperative complications. 13 cases that underwent this technique were free of complications during postoperative follow-up, and the intraoperative anastomosis time was significantly shorter than that reported in the literature for Double-flap technique (45 min vs. 79-114 min).

Methods and analysis: This is a single-center, single-arm, prospective clinical study. We will recruit 30 eligible patients consecutively to undergo HEFT. The primary objective is to assess perioperative safety. The secondary objectives: (1) Incidence of postoperative reflux esophagitis and anastomotic stenosis; (2) Assess the quality of life at 3 Months Postoperatively by EORTC QLQ-C30 and EORTC QLQ-STO22 scales. Measurement data will be presented as mean ± standard deviation (x¯± s). Count data will be presented as rates (%).

导读:在过去,全胃切除术(TG)是最常见的手术方式,而现在近端胃切除术(PG)逐渐成为治疗胃近端及食管胃交界癌的替代手术方式。然而,PG术后没有公认的首选吻合方式。鉴于此,笔者团队提出的Hao食管胃吻合术(HEFT)可以降低手术难度和术后并发症的发生。13例术后随访无并发症,术中吻合时间明显短于文献报道的双瓣吻合(45 min vs. 79 ~ 114 min)。方法与分析:这是一项单中心、单臂、前瞻性临床研究。我们将连续招募30例符合条件的患者进行HEFT。主要目的是评估围手术期的安全性。次要目的:(1)术后反流性食管炎和吻合口狭窄的发生率;(2)采用EORTC QLQ-C30和EORTC QLQ-STO22量表评估术后3个月生活质量。测量数据将以平均值±标准差(x¯±s)表示。计数数据将以比率(%)表示。
{"title":"Advantages of Hao's esophagogastrostomy by fissure technique: study protocol for a prospective clinical trial.","authors":"Wen-Liang Cui, Ze-Qin Wang, Ming-Ye Ma, Ya-Ping Wang, Lu-Chun Hua, Jun Hong, Han-Kun Hao","doi":"10.1080/20565623.2025.2540746","DOIUrl":"10.1080/20565623.2025.2540746","url":null,"abstract":"<p><strong>Introduction: </strong>In the past, total gastrectomy (TG) was the most common surgical method, but now proximal gastrectomy (PG) has gradually become an alternative surgical method for proximal gastric and esophagogastric junction cancer. However, there is no recognized preferred anastomosis method after PG. In view of this, Hao's esophagogastrostomy by fissure technique (HEFT) proposed by the author's team can reduce the difficulty of the operation and the occurrence of postoperative complications. 13 cases that underwent this technique were free of complications during postoperative follow-up, and the intraoperative anastomosis time was significantly shorter than that reported in the literature for Double-flap technique (45 min vs. 79-114 min).</p><p><strong>Methods and analysis: </strong>This is a single-center, single-arm, prospective clinical study. We will recruit 30 eligible patients consecutively to undergo HEFT. The primary objective is to assess perioperative safety. The secondary objectives: (1) Incidence of postoperative reflux esophagitis and anastomotic stenosis; (2) Assess the quality of life at 3 Months Postoperatively by EORTC QLQ-C30 and EORTC QLQ-STO22 scales. Measurement data will be presented as mean ± standard deviation (<math><mrow><mrow><mover><mrow><mrow><mi>x</mi></mrow></mrow><mo>¯</mo></mover></mrow><mo> </mo><mo>±</mo><mtext> s</mtext></mrow></math>). Count data will be presented as rates (%).</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2540746"},"PeriodicalIF":2.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12309549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144729628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The perioperative implications of the patient with Obstructive Sleep Apnea (OSA) - a narrative review. 阻塞性睡眠呼吸暂停(OSA)患者围手术期的意义-一篇叙述性综述。
IF 2.1 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2025-08-01 DOI: 10.1080/20565623.2025.2540744
Erin Tracy, Cole Crandall, Ana Grajales, Anthony Plunkett

The prevalence of obesity and OSA are increasing world-wide. Concomitantly, the number of surgical procedures being performed in an outpatient setting is increasing. Both the American Society of Anesthesiology (ASA) and the Society of Anesthesia and Sleep Medicine (SASM) have published guidelines for the perioperative care of the OSA patient. These guidelines were published in 2014 and 2016, respectively. While they serve as an excellent resource for the perioperative management of the OSA patient, the increasing number of obese, OSA patients having procedures performed in the ambulatory setting call into question the feasibility of some of these recommendations in 2024. This review highlights the current recommendations as well as the challenges in caring for the OSA patient in the perioperative setting.

肥胖症和阻塞性睡眠呼吸暂停的患病率在世界范围内呈上升趋势。与此同时,在门诊环境中进行的外科手术的数量也在增加。美国麻醉学学会(ASA)和麻醉与睡眠医学学会(SASM)都发布了OSA患者围手术期护理指南。这些指南分别于2014年和2016年发布。虽然它们是OSA患者围手术期管理的优秀资源,但越来越多的肥胖OSA患者在门诊环境中进行手术,这对2024年一些建议的可行性提出了质疑。这篇综述强调了目前的建议以及在围手术期护理OSA患者的挑战。
{"title":"The perioperative implications of the patient with Obstructive Sleep Apnea (OSA) - a narrative review.","authors":"Erin Tracy, Cole Crandall, Ana Grajales, Anthony Plunkett","doi":"10.1080/20565623.2025.2540744","DOIUrl":"10.1080/20565623.2025.2540744","url":null,"abstract":"<p><p>The prevalence of obesity and OSA are increasing world-wide. Concomitantly, the number of surgical procedures being performed in an outpatient setting is increasing. Both the American Society of Anesthesiology (ASA) and the Society of Anesthesia and Sleep Medicine (SASM) have published guidelines for the perioperative care of the OSA patient. These guidelines were published in 2014 and 2016, respectively. While they serve as an excellent resource for the perioperative management of the OSA patient, the increasing number of obese, OSA patients having procedures performed in the ambulatory setting call into question the feasibility of some of these recommendations in 2024. This review highlights the current recommendations as well as the challenges in caring for the OSA patient in the perioperative setting.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2540744"},"PeriodicalIF":2.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12320865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144759810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in oral cryotherapy for the management of anticancer therapy-induced oral mucositis. 口腔冷冻治疗抗癌治疗引起的口腔黏膜炎的最新进展。
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2025-07-03 DOI: 10.1080/20565623.2025.2527500
Feng Lin Hu, Ni Lou, Guo Lin Wu

Oral mucositis (OM) is a prevalent complication of cancer therapy, frequently associated with oral pain, dysphagia, malnutrition, and systemic infections. OM that develops during cancer treatment can result in delays or interruptions in anti-cancer therapies, significantly impacting patients' quality of life. Oral cryotherapy (OC) involves the use of crushed ice, specialized cryotherapy devices, and other cooling methods to lower the temperature in the oral cavity during chemotherapy or radiotherapy, thereby reducing the incidence and severity of cancer treatment-related OM. This review aims to elucidate the role of OC in managing OM induced by anticancer therapy by summarizing the mechanisms, specific operational procedures, and potential adverse reactions associated with cryotherapy for OM. It also compares the efficacy of cryotherapy with other preventive and therapeutic approaches for OM, as well as their combined applications. While cryotherapy demonstrates effectiveness in preventing the incidence and severity of cancer treatment-related OM, it is not effective for OM that has already been formed because of previous treatments. Therefore, integrating cryotherapy with basic oral care, photobiomodulation therapy, pharmacological interventions, traditional Chinese medicine, and other modalities is essential for optimal prevention and management of cancer treatment-related OM.

口腔黏膜炎(OM)是癌症治疗的常见并发症,常伴有口腔疼痛、吞咽困难、营养不良和全身感染。在癌症治疗过程中产生的OM会导致抗癌治疗的延迟或中断,严重影响患者的生活质量。口服冷冻疗法(OC)是指在化疗或放疗期间使用碎冰、专门的冷冻治疗装置和其他冷却方法来降低口腔温度,从而降低与癌症治疗相关的OM的发病率和严重程度。本文旨在通过总结冷冻治疗骨髓瘤的机制、具体操作程序和潜在不良反应,阐明骨髓瘤在抗癌治疗诱导骨髓瘤中的作用。它还比较了冷冻疗法与其他OM预防和治疗方法的疗效,以及它们的联合应用。虽然冷冻疗法在预防与癌症治疗相关的OM的发生和严重程度方面显示出有效性,但对于由于以前的治疗而已经形成的OM并不有效。因此,将冷冻治疗与基础口腔护理、光生物调节治疗、药物干预、中药等方式相结合,对癌症治疗相关OM的最佳预防和管理至关重要。
{"title":"Recent advances in oral cryotherapy for the management of anticancer therapy-induced oral mucositis.","authors":"Feng Lin Hu, Ni Lou, Guo Lin Wu","doi":"10.1080/20565623.2025.2527500","DOIUrl":"10.1080/20565623.2025.2527500","url":null,"abstract":"<p><p>Oral mucositis (OM) is a prevalent complication of cancer therapy, frequently associated with oral pain, dysphagia, malnutrition, and systemic infections. OM that develops during cancer treatment can result in delays or interruptions in anti-cancer therapies, significantly impacting patients' quality of life. Oral cryotherapy (OC) involves the use of crushed ice, specialized cryotherapy devices, and other cooling methods to lower the temperature in the oral cavity during chemotherapy or radiotherapy, thereby reducing the incidence and severity of cancer treatment-related OM. This review aims to elucidate the role of OC in managing OM induced by anticancer therapy by summarizing the mechanisms, specific operational procedures, and potential adverse reactions associated with cryotherapy for OM. It also compares the efficacy of cryotherapy with other preventive and therapeutic approaches for OM, as well as their combined applications. While cryotherapy demonstrates effectiveness in preventing the incidence and severity of cancer treatment-related OM, it is not effective for OM that has already been formed because of previous treatments. Therefore, integrating cryotherapy with basic oral care, photobiomodulation therapy, pharmacological interventions, traditional Chinese medicine, and other modalities is essential for optimal prevention and management of cancer treatment-related OM.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2527500"},"PeriodicalIF":2.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233692/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144553113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distinct somatic mutation profiles in colon cancer by behavioral comorbidity. 不同的体细胞突变谱在结肠癌的行为合并症。
IF 2.1 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2025-09-18 DOI: 10.1080/20565623.2025.2561501
Raphael E Cuomo

Background: Tobacco use, obesity, and type 2 diabetes are risk factors for colorectal cancer, but whether they generate distinct tumor mutation patterns is unclear. Tobacco is a known mutagen, while obesity and diabetes may act through metabolic and inflammatory pathways.

Methods: We analyzed colon cancer patients from the University of California Health Data Warehouse, linking clinical sequencing data to diagnosis-based indicators of tobacco dependence, obesity, and type 2 diabetes. For each gene-behavior pair, we conducted reverse logistic regressions and calculated a combined score reflecting the strength and specificity of association adjusting for demographic covariates and cancer stage. Multidimensional scaling and clustering assessed behavioral differentiation.

Results: Of 981 gene-behavior tests, 87 pairs exhibited a behavioral association at p < 0.001 in adjusted models. Of these, 60 tobacco, 12 obesity, and 9 diabetes pairs had affinity ≥0.5; 48 tobacco pairs exceeded 1.0. Mean (SD) combined scores were 1.39 (0.79) for tobacco, 1.24 (0.88) for obesity, and 0.74 (0.39) for diabetes. Exemplars included KEAP1 and CDKN2A (tobacco), ASPSCR1 and PGR (obesity), and a smaller diabetes signal led by MAF.

Conclusions: Tobacco dependence is associated with a more mutagenic and distinct somatic mutation profile in colon cancer, suggesting fundamental differences in behavioral mechanisms of carcinogenesis.

背景:吸烟、肥胖和2型糖尿病是结直肠癌的危险因素,但它们是否会产生不同的肿瘤突变模式尚不清楚。烟草是一种已知的诱变剂,而肥胖和糖尿病可能通过代谢和炎症途径起作用。方法:我们分析了来自加州大学健康数据仓库的结肠癌患者,将临床测序数据与烟草依赖、肥胖和2型糖尿病的诊断指标联系起来。对于每个基因-行为对,我们进行了反向逻辑回归,并计算了一个综合评分,反映了人口统计学协变量和癌症分期的关联强度和特异性。多维尺度和聚类评估行为分化。结果:在981个基因-行为测试中,87对显示出行为相关p。结论:烟草依赖与结肠癌中更具诱变性和独特的体细胞突变谱相关,表明致癌的行为机制存在根本差异。
{"title":"Distinct somatic mutation profiles in colon cancer by behavioral comorbidity.","authors":"Raphael E Cuomo","doi":"10.1080/20565623.2025.2561501","DOIUrl":"10.1080/20565623.2025.2561501","url":null,"abstract":"<p><strong>Background: </strong>Tobacco use, obesity, and type 2 diabetes are risk factors for colorectal cancer, but whether they generate distinct tumor mutation patterns is unclear. Tobacco is a known mutagen, while obesity and diabetes may act through metabolic and inflammatory pathways.</p><p><strong>Methods: </strong>We analyzed colon cancer patients from the University of California Health Data Warehouse, linking clinical sequencing data to diagnosis-based indicators of tobacco dependence, obesity, and type 2 diabetes. For each gene-behavior pair, we conducted reverse logistic regressions and calculated a combined score reflecting the strength and specificity of association adjusting for demographic covariates and cancer stage. Multidimensional scaling and clustering assessed behavioral differentiation.</p><p><strong>Results: </strong>Of 981 gene-behavior tests, 87 pairs exhibited a behavioral association at <i>p</i> < 0.001 in adjusted models. Of these, 60 tobacco, 12 obesity, and 9 diabetes pairs had affinity ≥0.5; 48 tobacco pairs exceeded 1.0. Mean (SD) combined scores were 1.39 (0.79) for tobacco, 1.24 (0.88) for obesity, and 0.74 (0.39) for diabetes. Exemplars included KEAP1 and CDKN2A (tobacco), ASPSCR1 and PGR (obesity), and a smaller diabetes signal led by MAF.</p><p><strong>Conclusions: </strong>Tobacco dependence is associated with a more mutagenic and distinct somatic mutation profile in colon cancer, suggesting fundamental differences in behavioral mechanisms of carcinogenesis.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2561501"},"PeriodicalIF":2.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12452446/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145080388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic review of scapular Ewing's sarcoma and a rare case of massive pleural effusion as primary manifestation. 肩胛骨尤文氏肉瘤1例以大量胸腔积液为主要表现。
IF 2.1 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2025-09-30 DOI: 10.1080/20565623.2025.2567163
Hela Cherif, Haifa Ben Romdhane, Sarra Ben Rejeb, Soumaya Debiche, Mehdi Charfi, Ferdaous Yangui, Imen Bouassida, Salma Mokaddem, Mohamed Ridha Charfi

Background: Ewing Sarcoma (ES) ranks second among mesenchymal malignancies in children and young adults. Scapular Ewing sarcoma (SES) represents <4% of ES cases with limited literature. We report a case of SES with uncommon respiratory symptoms in a 37-year-old male and conduct a systematic review to improve comprehension of SES demographics, clinical attributes, and management.

Literature review: A systematic search was conducted in PubMed, Scopus, and Google Scholar including SES case reports and series from 1983 to 2024. Using Covidence, references were screened. Two reviewers independently assessed eligibility, resulting in the inclusion of 32 studies. Risk of bias was assessed using Joanna Briggs Institute (JBI) checklists. A total of 124 SES cases were analyzed. SES predominantly affected adolescents with median age of 16 years; IQR: 12-24, and most commonly presented with shoulder swelling. A case within this cohort exhibited respiratory symptoms. Metastases occurred in 30% of cases, mainly to the lungs and bones. Remission was achieved in 64% of cases, while 29.7% had fatal outcomes.

Conclusion: This review highlights the predominance of shoulder symptoms and identifies a unique respiratory presentation. Given the high metastatic rate, standardized protocols are needed to ensure oncological control and preserve shoulder function.

Registration: PROSPERO,CRD420251008692.

背景:Ewing肉瘤(ES)在儿童和青少年间充质恶性肿瘤中排名第二。文献综述:系统检索PubMed、Scopus和谷歌Scholar,包括1983 - 2024年的SES病例报告和系列。使用Covidence对参考文献进行筛选。两名审稿人独立评估了入选资格,最终纳入了32项研究。使用乔安娜布里格斯研究所(JBI)的检查表评估偏倚风险。共分析124例SES病例。SES主要影响中位年龄16岁的青少年;IQR: 12-24,最常表现为肩部肿胀。该队列中有一例出现呼吸道症状。30%的病例发生转移,主要转移到肺部和骨骼。64%的病例缓解,29.7%的患者死亡。结论:这篇综述强调了肩部症状的优势,并确定了一个独特的呼吸表现。鉴于高转移率,需要标准化的方案来确保肿瘤控制和保持肩部功能。注册:普洛斯彼罗,CRD420251008692。
{"title":"Systematic review of scapular Ewing's sarcoma and a rare case of massive pleural effusion as primary manifestation.","authors":"Hela Cherif, Haifa Ben Romdhane, Sarra Ben Rejeb, Soumaya Debiche, Mehdi Charfi, Ferdaous Yangui, Imen Bouassida, Salma Mokaddem, Mohamed Ridha Charfi","doi":"10.1080/20565623.2025.2567163","DOIUrl":"10.1080/20565623.2025.2567163","url":null,"abstract":"<p><strong>Background: </strong>Ewing Sarcoma (ES) ranks second among mesenchymal malignancies in children and young adults. Scapular Ewing sarcoma (SES) represents <4% of ES cases with limited literature. We report a case of SES with uncommon respiratory symptoms in a 37-year-old male and conduct a systematic review to improve comprehension of SES demographics, clinical attributes, and management.</p><p><strong>Literature review: </strong>A systematic search was conducted in PubMed, Scopus, and Google Scholar including SES case reports and series from 1983 to 2024. Using Covidence, references were screened. Two reviewers independently assessed eligibility, resulting in the inclusion of 32 studies. Risk of bias was assessed using Joanna Briggs Institute (JBI) checklists. A total of 124 SES cases were analyzed. SES predominantly affected adolescents with median age of 16 years; IQR: 12-24, and most commonly presented with shoulder swelling. A case within this cohort exhibited respiratory symptoms. Metastases occurred in 30% of cases, mainly to the lungs and bones. Remission was achieved in 64% of cases, while 29.7% had fatal outcomes.</p><p><strong>Conclusion: </strong>This review highlights the predominance of shoulder symptoms and identifies a unique respiratory presentation. Given the high metastatic rate, standardized protocols are needed to ensure oncological control and preserve shoulder function.</p><p><strong>Registration: </strong>PROSPERO,CRD420251008692.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2567163"},"PeriodicalIF":2.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12490403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145199000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sleeve gastrectomy for morbid obesity: weight loss trajectory and failure predictors over a decade. 袖式胃切除术治疗病态肥胖:十年来的体重减轻轨迹和失败预测。
IF 2.1 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.1080/20565623.2025.2594236
Asma Sghaier, Fehmi Hamila, Amal Letaief, Mohamed Hédi Mraidha, Zeineb Maatoug, Marwa Bouzid, Mohamed Amine Elghali, Sabri Youssef

Background: Sleeve gastrectomy (SG) is an effective treatment for morbid obesity, promoting weight loss and resolving related comorbidities.

Methods: This prospective, observational study involved 100 patients undergoing SG at Farhat Hached Hospital, Sousse, between February 2009 and December 2019.

Results: Patients had a mean age of 34 ± 9.9 years and a mean BMI of 46.2 ± 7.8 kg/m2. Preexisting conditions included type 2 diabetes (16%), hypertension (18%), dyslipidemia (13%), and obstructive sleep apnea (OSA) (29%). Eating disorders were prevalent (98%), notably binge eating (87%). Mortality was 0%, with 12% early morbidity. Maximum of Excess weight loss (EWL) reached 59 ± 19% at 24 months (with a maximum Total Weight Loss (%TWL) of 30 ± 7.9%) but declined to 30% by 10 years. Comorbidity remission rates were significant: 68.7% for diabetes, 27.7% for hypertension, and 46% for dyslipidemia. OSA improved in 86% of cases. The overall success rate (EWL >50%) was 61%, with 39% experiencing insufficient weight loss or regain. Predictors of failure identified through multivariate analysis included hypertension, diabetes, age >40 years, preoperative BMI > 40 kg/m2, postoperative dietary lapses, and a sedentary lifestyle.

Conclusions: Our findings demonstrate that sleeve gastrectomy offers substantial initial weight loss, with the maximum Excess Weight Loss (EWL) achieved at 2 years. However, this weight loss diminishes over the long term, with long-term data (up to a decade) requiring cautious interpretation due to high attrition. A comprehensive understanding of factors influencing long-term success is vital for improving patient care.

背景:袖胃切除术(SG)是一种有效的治疗病态肥胖,促进体重减轻和解决相关合并症。方法:这项前瞻性观察性研究纳入了2009年2月至2019年12月期间在苏塞Farhat Hached医院接受SG治疗的100例患者。结果:患者平均年龄34±9.9岁,平均BMI为46.2±7.8 kg/m2。既往疾病包括2型糖尿病(16%)、高血压(18%)、血脂异常(13%)和阻塞性睡眠呼吸暂停(OSA)(29%)。饮食失调很普遍(98%),尤其是暴食(87%)。死亡率为0%,早期发病率为12%。24个月时最大体重减重(EWL)为59±19%(最大总体重减重(%TWL)为30±7.9%),10年后下降至30%。合并症缓解率显著:糖尿病为68.7%,高血压为27.7%,血脂异常为46%。86%的患者的OSA得到改善。总体成功率(EWL bbb50 %)为61%,39%的患者体重减轻或恢复不足。通过多变量分析确定的失败预测因素包括高血压、糖尿病、年龄> ~ 40岁、术前BMI > ~ 40 kg/m2、术后饮食失误和久坐不动的生活方式。结论:我们的研究结果表明,袖式胃切除术提供了大量的初始体重减轻,最大的体重减轻(EWL)达到2年。然而,这种体重减轻在长期内会逐渐减少,长期数据(长达十年)需要谨慎的解释,因为高损耗率。全面了解影响长期成功的因素对改善病人护理至关重要。
{"title":"Sleeve gastrectomy for morbid obesity: weight loss trajectory and failure predictors over a decade.","authors":"Asma Sghaier, Fehmi Hamila, Amal Letaief, Mohamed Hédi Mraidha, Zeineb Maatoug, Marwa Bouzid, Mohamed Amine Elghali, Sabri Youssef","doi":"10.1080/20565623.2025.2594236","DOIUrl":"10.1080/20565623.2025.2594236","url":null,"abstract":"<p><strong>Background: </strong>Sleeve gastrectomy (SG) is an effective treatment for morbid obesity, promoting weight loss and resolving related comorbidities.</p><p><strong>Methods: </strong>This prospective, observational study involved 100 patients undergoing SG at Farhat Hached Hospital, Sousse, between February 2009 and December 2019.</p><p><strong>Results: </strong>Patients had a mean age of 34 ± 9.9 years and a mean BMI of 46.2 ± 7.8 kg/m<sup>2</sup>. Preexisting conditions included type 2 diabetes (16%), hypertension (18%), dyslipidemia (13%), and obstructive sleep apnea (OSA) (29%). Eating disorders were prevalent (98%), notably binge eating (87%). Mortality was 0%, with 12% early morbidity. Maximum of Excess weight loss (EWL) reached 59 ± 19% at 24 months (with a maximum Total Weight Loss (%TWL) of 30 ± 7.9%) but declined to 30% by 10 years. Comorbidity remission rates were significant: 68.7% for diabetes, 27.7% for hypertension, and 46% for dyslipidemia. OSA improved in 86% of cases. The overall success rate (EWL >50%) was 61%, with 39% experiencing insufficient weight loss or regain. Predictors of failure identified through multivariate analysis included hypertension, diabetes, age >40 years, preoperative BMI > 40 kg/m<sup>2</sup>, postoperative dietary lapses, and a sedentary lifestyle.</p><p><strong>Conclusions: </strong>Our findings demonstrate that sleeve gastrectomy offers substantial initial weight loss, with the maximum Excess Weight Loss (EWL) achieved at 2 years. However, this weight loss diminishes over the long term, with long-term data (up to a decade) requiring cautious interpretation due to high attrition. A comprehensive understanding of factors influencing long-term success is vital for improving patient care.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2594236"},"PeriodicalIF":2.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12674430/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colonic strictures in Crohn's disease: a non-surgical survival. 结肠狭窄在克罗恩病:非手术生存。
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2025-01-25 DOI: 10.1080/20565623.2025.2455911
Sarra Laabidi, Hamed Aboubecrine, Salma Souissi, Donia Gouiaa, Asma Labidi, Nadia Ben Mustapha, Anis Haddad, Amine Sebai, Meriem Serghini, Monia Fekih, Hanene Jaziri, Jalel Boubaker

Background: Colonic stenosis in Crohn's disease (CD) is uncommon, and data on surgery-free survival are limited. This study aimed to determine surgery-free survival rates and identify associated factors.

Patients and methods: A retrospective study was conducted from 2003 to 2022, including patients with CD complicated by colonic stenosis. Patients with uncertain diagnoses or follow-up periods of less than six months were excluded.

Results: Fifty-six patients were included (median age 44 years [range 14-65], male-to-female ratio = 0.93). Surgery-free survival rates were 58.9% at 6 months, 43.7% at 2 years, and 31.7% at 5 years, with an average surgery-free survival of 46.7 months. Univariate analysis showed that joint manifestations (p = 0.01), corticosteroids (p = 0.02), anti-TNF alpha (p = 0.02), salicylates (p = 0.02), and azathioprine (p = 0.01) increased surgery-free survival. Complications such as collections or internal fistulas (p = 0.03), parietal ulceration on imaging (p = 0.01), and acute intestinal obstruction (p = 0.01) were associated with reduced surgery-free survival. In multivariate analysis, biologic therapy was the only independent protective factor against surgery (p = 0.001, OR = 0.19).

Conclusion: The early introduction of biologic therapy is crucial for increasing surgery-free survival in patients with colonic stenosis in CD, given the limited effectiveness of conventional treatments.

背景:克罗恩病(CD)的结肠狭窄并不常见,无手术生存的数据有限。本研究旨在确定无手术生存率并确定相关因素。患者和方法:2003年至2022年进行回顾性研究,包括CD合并结肠狭窄的患者。诊断不明确或随访时间少于6个月的患者被排除在外。结果:纳入56例患者(中位年龄44岁[范围14-65],男女比= 0.93)。6个月时的无手术生存率为58.9%,2年时为43.7%,5年时为31.7%,平均无手术生存率为46.7个月。单因素分析显示,关节表现(p = 0.01)、皮质类固醇(p = 0.02)、抗肿瘤坏死因子α (p = 0.02)、水杨酸盐(p = 0.02)和硫唑嘌呤(p = 0.01)增加了无手术生存。并发症如收集或内瘘(p = 0.03),影像学上的壁溃疡(p = 0.01)和急性肠梗阻(p = 0.01)与减少的无手术生存率相关。在多变量分析中,生物治疗是对手术唯一的独立保护因素(p = 0.001, OR = 0.19)。结论:鉴于常规治疗的有效性有限,早期引入生物治疗对于提高CD结肠狭窄患者的无手术生存率至关重要。
{"title":"Colonic strictures in Crohn's disease: a non-surgical survival.","authors":"Sarra Laabidi, Hamed Aboubecrine, Salma Souissi, Donia Gouiaa, Asma Labidi, Nadia Ben Mustapha, Anis Haddad, Amine Sebai, Meriem Serghini, Monia Fekih, Hanene Jaziri, Jalel Boubaker","doi":"10.1080/20565623.2025.2455911","DOIUrl":"10.1080/20565623.2025.2455911","url":null,"abstract":"<p><strong>Background: </strong>Colonic stenosis in Crohn's disease (CD) is uncommon, and data on surgery-free survival are limited. This study aimed to determine surgery-free survival rates and identify associated factors.</p><p><strong>Patients and methods: </strong>A retrospective study was conducted from 2003 to 2022, including patients with CD complicated by colonic stenosis. Patients with uncertain diagnoses or follow-up periods of less than six months were excluded.</p><p><strong>Results: </strong>Fifty-six patients were included (median age 44 years [range 14-65], male-to-female ratio = 0.93). Surgery-free survival rates were 58.9% at 6 months, 43.7% at 2 years, and 31.7% at 5 years, with an average surgery-free survival of 46.7 months. Univariate analysis showed that joint manifestations (p = 0.01), corticosteroids (p = 0.02), anti-TNF alpha (p = 0.02), salicylates (p = 0.02), and azathioprine (p = 0.01) increased surgery-free survival. Complications such as collections or internal fistulas (p = 0.03), parietal ulceration on imaging (p = 0.01), and acute intestinal obstruction (p = 0.01) were associated with reduced surgery-free survival. In multivariate analysis, biologic therapy was the only independent protective factor against surgery (p = 0.001, OR = 0.19).</p><p><strong>Conclusion: </strong>The early introduction of biologic therapy is crucial for increasing surgery-free survival in patients with colonic stenosis in CD, given the limited effectiveness of conventional treatments.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2455911"},"PeriodicalIF":2.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11776860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A phytotherapeutic approach to hinder the resistance against clindamycin by MRSA: in vitro and in silico studies. 通过MRSA抑制克林霉素耐药性的植物治疗方法:体外和计算机研究。
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2025-02-02 DOI: 10.1080/20565623.2025.2458438
Amal Mayyas, Ali Al-Samydai, Nehaya Al-Karablieh, Waleed A Zalloum, Deniz Al-Tawalbeh, Farah Al-Mamoori, Rula A Amr, Hamdi Al Nsairat, Simone Carradori, Lidia Kamal Al-Halaseh, Talal Aburjai

Aims: This study investigates the potential effects of essential oils (EOs) in enhancing the efficacy of clindamycin against Methicillin-resistant Staphylococcus aureus (MRSA) using in vitro and computer simulations. The research seeks to identify essential oils that exhibit synergistic activity with clindamycin and determine their potential key active components.

Materials and methods: Essential oils commonly used in traditional medicine were tested for their antimicrobial activity against MRSA. The minimum inhibitory concentration (MIC) was determined using in vitro microdilution assays. A synergistic test with clindamycin was performed, and molecular docking studies evaluated the interaction between a key compound (trans-cinnamaldehyde) and MRSA protein.

Results: EOs from Cinnamomum verum, Rosmarinus officinalis, Salvia officinalis, and Thymus vulgaris demonstrated significant inhibitory and synergistic activities against MRSA, standard strain, and human clinical isolates. Gas Chromatography/Mass Spectroscopy identified trans-cinnamaldehyde, eucalyptol, and thymol as prominent antibacterial compounds. Molecular docking studies confirmed trans-cinnamaldehyde's strong binding to MRSA's AgrA protein, elucidating its enhanced efficacy.

Conclusion: The study underscores the potential of plant-based therapies to augment the effectiveness of conventional antibiotics like clindamycin in combating MRSA and addressing antibiotic resistance by integrating traditional plant remedies with modern medical approaches.

目的:通过体外实验和计算机模拟研究精油(EOs)对克林霉素抗耐甲氧西林金黄色葡萄球菌(MRSA)的潜在作用。该研究旨在确定精油与克林霉素的协同作用,并确定其潜在的关键活性成分。材料和方法:研究了传统医学中常用的精油对MRSA的抗菌活性。最低抑菌浓度(MIC)采用体外微量稀释法测定。进行了与克林霉素的协同试验,并进行了分子对接研究,评估了关键化合物(反式肉桂醛)与MRSA蛋白之间的相互作用。结果:肉桂、迷迭香、鼠尾草和寻常胸腺提取物对MRSA、标准菌株和人临床分离株均有显著的抑制和协同作用。气相色谱/质谱鉴定出反式肉桂醛、桉树醇和百里香酚是主要的抗菌化合物。分子对接研究证实了反式肉桂醛与MRSA的AgrA蛋白的强结合,阐明了其增强的功效。结论:该研究强调了基于植物的疗法的潜力,通过将传统植物疗法与现代医学方法相结合,可以增强克林霉素等传统抗生素在对抗MRSA和解决抗生素耐药性方面的有效性。
{"title":"A phytotherapeutic approach to hinder the resistance against clindamycin by MRSA: <i>in vitro</i> and <i>in silico</i> studies.","authors":"Amal Mayyas, Ali Al-Samydai, Nehaya Al-Karablieh, Waleed A Zalloum, Deniz Al-Tawalbeh, Farah Al-Mamoori, Rula A Amr, Hamdi Al Nsairat, Simone Carradori, Lidia Kamal Al-Halaseh, Talal Aburjai","doi":"10.1080/20565623.2025.2458438","DOIUrl":"10.1080/20565623.2025.2458438","url":null,"abstract":"<p><strong>Aims: </strong>This study investigates the potential effects of essential oils (EOs) in enhancing the efficacy of clindamycin against Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) using <i>in vitro</i> and computer simulations. The research seeks to identify essential oils that exhibit synergistic activity with clindamycin and determine their potential key active components.</p><p><strong>Materials and methods: </strong>Essential oils commonly used in traditional medicine were tested for their antimicrobial activity against MRSA. The minimum inhibitory concentration (MIC) was determined using <i>in vitro</i> microdilution assays. A synergistic test with clindamycin was performed, and molecular docking studies evaluated the interaction between a key compound (<i>trans</i>-cinnamaldehyde) and MRSA protein.</p><p><strong>Results: </strong>EOs from <i>Cinnamomum verum</i>, <i>Rosmarinus officinalis</i>, <i>Salvia officinalis</i>, and <i>Thymus vulgaris</i> demonstrated significant inhibitory and synergistic activities against MRSA, standard strain, and human clinical isolates. Gas Chromatography/Mass Spectroscopy identified <i>trans</i>-cinnamaldehyde, eucalyptol, and thymol as prominent antibacterial compounds. Molecular docking studies confirmed <i>trans</i>-cinnamaldehyde's strong binding to MRSA's AgrA protein, elucidating its enhanced efficacy.</p><p><strong>Conclusion: </strong>The study underscores the potential of plant-based therapies to augment the effectiveness of conventional antibiotics like clindamycin in combating MRSA and addressing antibiotic resistance by integrating traditional plant remedies with modern medical approaches.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2458438"},"PeriodicalIF":2.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11792796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143079369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and risk factors of H. pylori infection among outpatient in Karaganda city (Kazakhstan). 哈萨克斯坦卡拉干达市门诊患者幽门螺杆菌感染流行及危险因素分析
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2025-02-10 DOI: 10.1080/20565623.2025.2461429
Aizhan Seisenbekova, Yelena Laryushina, Yekaterina Yukhnevich, Alyona Lavrinenko, Alexey Shkreba

Background: To better understand the factors associated with Helicobacter pylori infection, it is important to quantify the prevalence of H. pylori and identify the clinical and demographic characteristics of individuals with the infection.

Method: In this cross-sectional study 369 participants underwent a structured questionnaire, urease breath test, and endoscopy to determine their H. pylori status.

Results: The frequency of H. pylori in the sample was 27.64%, and erosive antral gastritis, gastric ulcers, and duodenal ulcers were found to be significantly associated with infection. However, no differences were found in social status, family size, or shared utensil use between individuals with and without the infection.

Conclusion: These findings suggest that H. pylori is a significant risk factor for gastrointestinal conditions.

背景:为了更好地了解幽门螺杆菌感染的相关因素,量化幽门螺杆菌的患病率并确定感染个体的临床和人口学特征是很重要的。方法:在这项横断面研究中,369名参与者接受了结构化问卷调查、脲酶呼吸测试和内窥镜检查,以确定他们的幽门螺杆菌状态。结果:样品中幽门螺杆菌感染率为27.64%,糜烂性胃窦炎、胃溃疡、十二指肠溃疡与感染有显著相关性。然而,在社会地位、家庭规模或共用餐具的使用方面,感染和未感染个体之间没有发现差异。结论:这些发现提示幽门螺旋杆菌是胃肠道疾病的重要危险因素。
{"title":"Prevalence and risk factors of <i>H. pylori</i> infection among outpatient in Karaganda city (Kazakhstan).","authors":"Aizhan Seisenbekova, Yelena Laryushina, Yekaterina Yukhnevich, Alyona Lavrinenko, Alexey Shkreba","doi":"10.1080/20565623.2025.2461429","DOIUrl":"10.1080/20565623.2025.2461429","url":null,"abstract":"<p><strong>Background: </strong>To better understand the factors associated with <i>Helicobacter pylori</i> infection, it is important to quantify the prevalence of <i>H. pylori</i> and identify the clinical and demographic characteristics of individuals with the infection.</p><p><strong>Method: </strong>In this cross-sectional study 369 participants underwent a structured questionnaire, urease breath test, and endoscopy to determine their <i>H. pylori</i> status.</p><p><strong>Results: </strong>The frequency of <i>H. pylori</i> in the sample was 27.64%, and erosive antral gastritis, gastric ulcers, and duodenal ulcers were found to be significantly associated with infection. However, no differences were found in social status, family size, or shared utensil use between individuals with and without the infection.</p><p><strong>Conclusion: </strong>These findings suggest that <i>H. pylori</i> is a significant risk factor for gastrointestinal conditions.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2461429"},"PeriodicalIF":2.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143382193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Future Science OA
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1